Gyroxin increases blood-brain barrier permeability to Evans blue dye in mice

Toxicon

Volumn 57, Issue 1, 2011, Pages 162-167

  Alves da Silva, J A ^a   Oliveira, K C ^a   Camillo, M A P ^a  

^a INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

Barrel rotation; Blood brain barrier; Crotalus durissus terrificus; Gyroxin; Serine protease

Indexed keywords

ALBUMIN; BRAIN EXTRACT; EVANS BLUE; GYROXIN; SNAKE VENOM; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARREL ROTATION SYNDROME; BLOOD BRAIN BARRIER; BRAIN TISSUE; CONTROLLED STUDY; EXPOSURE; GEL PERMEATION CHROMATOGRAPHY; MALE; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; MOUSE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TOXIN ANALYSIS;

CROTALUS DURISSUS TERRIFICUS; MUS;

EID: 78650676746     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.06.027     Document Type: Article

References (42)

1. Alexander G., Grothusen J., Zepeda H., Schwartzman R.J. Gyroxin, a toxin from the venom of Crotalus durissus terrificus, is a thrombin-like enzyme. Toxicon 1988, 26:953-960.
2. Alves da Silva J.A. Aspectos Estruturais e de Atividade Biológica da Giroxina (enzima trombina símile) do veneno da cascavel Brasileira, Crotalus durissus terrificus 2004, Universidade de Sao Paulo, Sao Paulo.
3. Alves da Silva J.A., Muramoto E., Ribela M.T.C.P., Rogero J.R., Camillo M.A.P. Biodistribution of gyroxin using 125I as radiotracer. J. Radioanal Nucl. Ch 2006, 269:579-583.
4. Ay I., Francis J.W., Brown R.H. VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice. Brain Res. 2008, 1234:198-205.
5. Barrabin, H., Martiarena, J.L., Vidal, J.C., Barrabin, H., 1978. Isolation and characterization of gyroxin from Crotalus durissus terrificus venom. In: Toxins: animal, plants and microbial. International Symposium on Animal, Plant, and Microbial Toxins, 113-133.
6. Barrio A. Gyroxin, a new neurotoxin of Crotalus durissus terrificus venom. Acta Physiol. La.t Am. 1961, 11:224-232.
7. Bollag D.M., Rozycki S.J., Edelstein S.J. Bradford assay. Protein Methods 1996, 62-67. Wiley-Liss Inc, New York.
8. Bondan E.F., Lallo M.A. Mielinização, desmielinização e remielinização no SNC: aspectos histológicos relevantes à formação e integridade da mielina central. Rev. Instit Ciência e. Saúde 1998, 16:103-111.
9. Camillo M.A., Arruda Paes P.C., Troncone L.R., Rogero J.R. Gyroxin fails to modify in vitro release of labelled dopamine and acetylcholine from rat and mouse striatal tissue. Toxicon 2001, 39:843-853.
10. Carvalho F.F., Nencioni A.L., Lebrun I., Dorce V.A., Sandoval M.R. Neurotoxic effects of three fractions isolated from Tityus serrulatus scorpion venom. Pharmacol. Toxicol. 2000, 86:149-155.
11. Cohn M.L., Cohn M. 'Barrel rotation' induced by somatostatin in the non-lesioned rat. Brain Res. 1975, 96:138-141.
12. Davies D.C. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J. Anat. 2002, 200:639-646.
13. Déry O., Corvera C.U., Steinhoff M., Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 1998, 274:C1429-C1452.
14. Diamant M., Baars A.M., Kovacs G.L., De Wied D. Barrel rotation induced by central arginine8-vasopressin treatment: involvement of neurohypophyseal peptide receptors. Pharmacol. Biochem. Behav. 1994, 47:27-32.
15. Guan J., Sun S., Cao X., Chen Z. Experimental study on the PAR-1 expression around hemotoma following intracerebral hemorrhage in rats. J. Huazhong Univ. Sci. Technolog Med. Sci. 2004, 24:266-268.
16. Hashizume, J.L., Camillo, M.A., 2005. Ação da giroxina em células endoteliais em cultura. In: Simpósio Internacional de Iniciação Científica da USP. Resumos do 13 SIICUSP-Ribeirão Preto/SP. 1, 3806.
17. Kahle K.T., Simard J.M., Staley K.J., Nahed B.V., Jones P.S., Sun D. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda) 2009, 24:257-265.
18. Kannan H., Tanaka H., Ueta Y., Hayashida Y., Kunitake T., Yamashita H. Effects of centrally administered endothelin-3 on renal sympathetic nerve activity and renal blood flow in conscious rats. J. Auton. Nerv. Syst. 1994, 49:105-113.
19. Kataoka H., Hamilton J.R., McKemy D.D., Camerer E., Zheng Y.W., Cheng A., Griffin C., Coughlin S.R. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 2003, 102:3224-3231.
20. Kawachi A., Miyashita M., Motoya T., Yamada K. The angiotensin AT1 receptor antagonist, losartan, induces barrel rotation in the rat. Eur. J. Pharmacol. 1998, 363:103-106.
21. Kaya M., Palanduz A., Kalayci R., Kemikler G., Simsek G., Bilgic B., Ahishali B., Arican N., Kocyildiz Z.C., Elmas I., Kucuk M., Karadeniz A. Effects of lipopolysaccharide on the radiation-induced changes in the blood-brain barrier and the astrocytes. Brain Res. 2004, 1019:105-112.
22. Kim Y.V., Di Cello F., Hillaire C.S., Kim K.S. Differential Ca2+ signaling by thrombin and protease-activated receptor-1-activating peptide in human brain microvascular endothelial cells. Am. J. Physiol. Cell Physiol. 2004, 286:C31-C42.
23. Kruse H., Van Wimersma Greidanus T.B., De Wied D. Barrel rotation induced by vasopressin and related peptides in rats. Pharmacol. Biochem. Behav. 1977, 7:311-313.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
25. Laquintana V., Trapani A., Denora N., Wang F., Gallo J.M., Trapani G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin. Drug Deliv. 2009, 6:1017-1032.
26. Leibowitz S., Hughes R.A.C. Immunology of the Nervous System/S. Leibowitz, R.A.C. Hughes 1983, Edward Arnold, London.
27. Minagar A., Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 2003, 9:540-549.
28. Misaki T., Satoh Y., Saino T., Ogawa A. The role of protease-activated receptors on the intracellular calcium ion dynamics of vascular smooth muscles, with special reference to cerebral arterioles. Arch. Histol. Cytol. 2006, 69:49-60.
29. Perez A.V., Rucavado A., Sanz L., Calvete J.J., Gutierrez J.M. Isolation and characterization of a serine proteinase with thrombin-like activity from the venom of the snake Bothrops asper. Braz. J. Med. Biol. Res. 2008, 41:12-17.
30. Rapoport S.I. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol. Neurobiol. 2000, 20:217-230.
31. Seiffert E., Dreier J.P., Ivens S., Bechmann I., Tomkins O., Heinemann U., Friedman A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 2004, 24:7829-7836.
32. da Silva G.H., Hyslop S., Alice da Cruz-Höfling M. Lonomia obliqua caterpillar venom increases permeability of the blood-brain barrier in rats. Toxicon 2004, 44:625-634.
33. Sternberg E.M., Mayer E.A., Saper C.B. Chapter 4 interactions between the immune and neuroendocrine systems. Progress in Brain Research 2000, 35-42. Elsevier.
34. Tétrault S., Chever O., Sik A., Amzica F. Opening of the blood-brain barrier during isoflurane anaesthesia. Eur. J. Neurosci. 2008, 28:1330-1341.
35. Torrent R.R.M., Bongiovanni B., Leiva L.C., Evangelista de Duffard A.M., Rodriguez J.P., Acosta de Perez O.C., Duffard R. Neurotoxicological effects of a thrombin-like enzyme isolated from Crotalus durissus terrificus venom (preliminary study). Toxicon 2007, 50:144-152.
36. Willcox B.J., Poulin P., Veale W.L., Pittman Q.J. Vasopressin-induced motor effects: localization of a sensitive site in the amygdala. Brain Res. 1992, 596:58-64.
37. Wilson C.M., Gaber M.W., Sabek O.M., Zawaski J.A., Merchant T.E. Radiation-induced astrogliosis and blood-brain barrier damage can be abrogated using anti-TNF treatment. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:934-941.
38. Wurpel J.N., Dundore R.L., Barbella Y.R., Balaban C.D., Keil L.C., Severs W.B. Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology. Brain Res. 1986, 365:21-29.
39. Wurpel J.N., Dundore R.L., Barbella Y.R., Balaban C.D., Keil L.C., Severs W.B. Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. II. Visual/vestibular interactions and efficacy of antiseizure drugs. Brain Res. 1986, 365:30-41.
40. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 2003, 112:1533-1540.
41. Yonamine C.M., Prieto-da-Silva A.R., Magalhaes G.S., Radis-Baptista G., Morganti L., Ambiel F.C., Chura-Chambi R.M., Yamane T., Camillo M.A. Cloning of serine protease cDNAs from Crotalus durissus terrificus venom gland and expression of a functional Gyroxin homologue in COS-7 cells. Toxicon 2009, 54:110-120.
42. Yoshizawa T., Shinmi O., Giaid A., Yanagisawa M., Gibson S.J., Kimura S., Uchiyama Y., Polak J.M., Masaki T., Kanazawa I. Endothelin: a novel peptide in the posterior pituitary system. Science 1990, 247:462-464.